{
    "eid": "2-s2.0-84908031784",
    "title": "CCNA1 promoter methylation: A potential marker for grading papanicolaou smear cervical squamous intraepithelial lesions",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Public Health",
            "@code": "2739"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Epidemiology",
            "@code": "2713"
        }
    ],
    "keywords": [
        "CCNA1 promoter methylation",
        "Cervical cancer",
        "Duplex MS-PCR",
        "HPV",
        "Pap smear"
    ],
    "authors": [
        "Suthipong Chujan"
    ],
    "citedby-count": 22,
    "ref-count": 33,
    "ref-list": [
        "The clinical utility of HPV DNA testing in cervical cancer screening strategies",
        "Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial",
        "Five-year experience of human papillomavirus DNA and papanicolaou test cotesting",
        "Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications",
        "Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis",
        "HPV detection methods and genotyping techniques in screening for cervical cancer",
        "A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women",
        "Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy",
        "Clinical prediction based on HPV DNA testing by hybrid capture 2 (HC2) in combination with liquid-based cytology (LBC)",
        "Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer",
        "DNA methylation changes in cervical cancers",
        "Clinical utility of HPV testing",
        "Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)",
        "The cyclin A1-CDK2 complex regulates DNA double-strand break repair",
        "Present standards for cervical cancer screening",
        "2012 cervical cancer screening guidelines and the future role of HPV testing",
        "Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of North-East India",
        "Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial",
        "Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening",
        "Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test",
        "Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial",
        "Cancer development, progression, and therapy: An epigenetic overview",
        "American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer",
        "HPV-mediated cervical carcinogenesis: Concepts and clinical implications",
        "High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening",
        "Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing",
        "Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): A randomised controlled non-inferiority trial",
        "PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions",
        "Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population",
        "Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma",
        "Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer",
        "Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}